Literature DB >> 10319055

Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol.

L P McGarvey1, L G Heaney, J T Lawson, B T Johnston, C M Scally, M Ennis, D R Shepherd, J MacMahon.   

Abstract

BACKGROUND: Asthma, post-nasal drip syndrome (PNDS), and gastro-oesophageal reflux (GOR) account for many cases of chronic non-productive cough (CNPC). Each may simultaneously contribute to cough even when clinically silent, and failure to recognise their contribution may lead to unsuccessful treatment.
METHODS: Patients (all lifetime non-smokers with normal chest radiographs and spirometric measurements) referred with CNPC persisting for more than three weeks as their sole respiratory symptom underwent histamine challenge, home peak flow measurements, ear, nose and throat (ENT) examination, sinus CT scanning, and 24 hour oesophageal pH monitoring. Treatment was prescribed on the basis of diagnoses informed by investigation results.
RESULTS: Forty three patients (29 women) of mean age 47.5 years (range 18-77) and mean cough duration 67 months (range 2-240) were evaluated. On the basis of a successful response to treatment, a cause for the cough was identified in 35 patients (82%) as follows: cough variant asthma (CVA) (10 cases), PNDS (9 cases), GOR (8 cases), and dual aetiologies (8 cases). Histamine challenge correctly predicted CVA in 15 of 17 (88%) positive tests. ENT examination and sinus CT scans each had low positive predictive values for PNDS (10 of 16 (63%) and 12 of 18 (67%) positive cases, respectively), suggesting that upper airways disease frequently co-exists but does not always contribute to cough. When negative, histamine challenge and 24 hour oesophageal pH monitoring effectively ruled out CVA and GOR, respectively, as a cause for cough.
CONCLUSION: This comprehensive approach aids the accurate direction of treatment and, while CVA, PNDS and GOR remain the most important causes of CNPC to consider, a group with no identifiable aetiology remains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10319055      PMCID: PMC1745317          DOI: 10.1136/thx.53.9.738

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Introduction and definition of sinusitis.

Authors:  G G Shapiro; G S Rachelefsky
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

2.  Chronic persistent cough and gastro-oesophageal reflux.

Authors:  A J Ing; M C Ngu; A B Breslin
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

3.  Twenty-four-hour ambulatory esophageal pH monitoring in the diagnosis of acid reflux-related chronic cough.

Authors:  M F Vaezi; J E Richter
Journal:  South Med J       Date:  1997-03       Impact factor: 0.954

4.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

5.  Cough and the common cold.

Authors:  F J Curley; R S Irwin; M R Pratter; D H Stivers; G V Doern; P A Vernaglia; A B Larkin; S P Baker
Journal:  Am Rev Respir Dis       Date:  1988-08

6.  Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.

Authors:  R S Irwin; C T French; N A Smyrnios; F J Curley
Journal:  Arch Intern Med       Date:  1997-09-22

Review 7.  Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease.

Authors:  H E Mattox; J E Richter
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

8.  Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy.

Authors:  R S Irwin; F J Curley; C L French
Journal:  Am Rev Respir Dis       Date:  1990-03

9.  Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol.

Authors:  R H Poe; R V Harder; R H Israel; M C Kallay
Journal:  Chest       Date:  1989-04       Impact factor: 9.410

10.  Symptom index as a marker of gastro-oesophageal reflux disease.

Authors:  B T Johnston; R J McFarland; J S Collins; A H Love
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

View more
  68 in total

Review 1.  Cough challenge in the assessment of cough reflex.

Authors:  A H Morice; J A Kastelik; R Thompson
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Cough. 3: chronic cough and gastro-oesophageal reflux.

Authors:  G A Fontana; M Pistolesi
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

3.  Case report: cough variant asthma.

Authors:  Anthony D'Urzo; Pieter Jugovic
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

Review 4.  Cough . 6: Which investigations are most useful in the diagnosis of chronic cough?

Authors:  L P A McGarvey
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

Review 5.  Cough: an unmet clinical need.

Authors:  Peter V Dicpinigaitis
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 7.  Cough. 1: Chronic cough in adults.

Authors:  A H Morice; J A Kastelik
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

9.  Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function.

Authors:  Peter V Dicpinigaitis; Yvonne E Gayle
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

10.  Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough.

Authors:  Amina Hamed Ahmad Al Obaidi
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.